AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimiyano-M2 Tablet PR

Prescription Icon
Prescription Required

Marketer

Yanolite Pharma Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimiyano-M2 Tablet PR

Diabex Duo tablets are a dual-action antidiabetic medication prescribed for adult patients with type 2 diabetes. This combination therapy helps regulate blood glucose levels. Diabex Duo should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use, even with controlled blood sugar, is crucial. Discontinuing treatment without medical consultation can lead to elevated blood sugar, potentially causing kidney complications, vision impairment, nerve damage, and limb loss. This medication forms part of a comprehensive diabetes management plan, incorporating a healthy diet, regular physical activity, and weight management as advised by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, dizziness, headache, and trembling. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption should be avoided due to its potential to exacerbate hypoglycemia. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver disease. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or breastfeeding women should seek medical advice prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.

Uses of Glimiyano-M2 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimiyano-M2 Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidance. Glimiyano-M2 Tablet PR should be administered with a meal.

Common Side effects of Glimiyano-M2 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimiyano-M2 Tablet PR:

Follow your physician's instructions or consult the product label for proper administration. Take Glimiyano-M2 Tablet PR with meals.

How Glimiyano-M2 Tablet PR works:

Glimiyano-M2 Tablet PR combines glimepiride, a sulfonylurea, and metformin, a biguanide, to manage blood sugar. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimiyano-M2 Tablet PR and alcohol poses a significant safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimiyano-M2 Tablet PR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should not use Glimiyano-M2 Tablet PR. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimiyano-M2 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician before use. Glimiyano-M2 Tablet PR is contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimiyano-M2 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician for guidance. A low initial dose is typically prescribed for those with mild to moderate liver disease; its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimiyano-M2 Tablet PR :

Should you forget a Glimiyano-M2 Tablet PR dose, ingest it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Glimiyano-M2 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimiyano-M2 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimiyano-M2 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glimiyano-M2 Tablet PR and seek immediate medical attention.
Glimiyano-M2 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. It's not suitable for type 1 DM.
Glimiyano-M2 Tablet PR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glimiyano-M2 Tablet PR use can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some research.
Glimiyano-M2 Tablet PR can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimiyano-M2 Tablet PR and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimiyano-M2 Tablet PR
193
MRP 223
13% off